[go: up one dir, main page]

DE122005000012I1 - N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate. - Google Patents

N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate.

Info

Publication number
DE122005000012I1
DE122005000012I1 DE200512000012 DE122005000012C DE122005000012I1 DE 122005000012 I1 DE122005000012 I1 DE 122005000012I1 DE 200512000012 DE200512000012 DE 200512000012 DE 122005000012 C DE122005000012 C DE 122005000012C DE 122005000012 I1 DE122005000012 I1 DE 122005000012I1
Authority
DE
Germany
Prior art keywords
ylacyl
glutamins
pyrrolo
pyrimidin
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE200512000012
Other languages
English (en)
Other versions
DE122005000012I2 (de
Inventor
Edward C Taylor
Dietmar G Kuhnt
Chuan Shih
Gerald B Grindey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Princeton University
Original Assignee
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27503964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000012(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/528,155 external-priority patent/US5028608A/en
Application filed by Princeton University filed Critical Princeton University
Publication of DE122005000012I1 publication Critical patent/DE122005000012I1/de
Publication of DE122005000012I2 publication Critical patent/DE122005000012I2/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE200512000012 1989-12-11 1990-12-10 N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl-Glutamins{urederivate Active DE122005000012I2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44874289A 1989-12-11 1989-12-11
US47965590A 1990-02-08 1990-02-08
US07/528,155 US5028608A (en) 1989-12-11 1990-05-24 N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US07/528,805 US4996206A (en) 1989-12-11 1990-05-24 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives

Publications (2)

Publication Number Publication Date
DE122005000012I1 true DE122005000012I1 (de) 2005-06-23
DE122005000012I2 DE122005000012I2 (de) 2006-02-09

Family

ID=27503964

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69025723T Expired - Lifetime DE69025723T2 (de) 1989-12-11 1990-12-10 N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate
DE200512000012 Active DE122005000012I2 (de) 1989-12-11 1990-12-10 N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl-Glutamins{urederivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69025723T Expired - Lifetime DE69025723T2 (de) 1989-12-11 1990-12-10 N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate

Country Status (21)

Country Link
EP (1) EP0432677B1 (de)
JP (1) JP3016876B2 (de)
CN (1) CN1030608C (de)
AR (1) AR245129A1 (de)
AT (1) ATE135007T1 (de)
AU (1) AU640182B2 (de)
CA (1) CA2031890C (de)
CY (1) CY2076B1 (de)
DE (2) DE69025723T2 (de)
DK (1) DK0432677T3 (de)
ES (1) ES2084639T4 (de)
GR (1) GR3019784T3 (de)
HU (1) HU218483B (de)
IE (1) IE904445A1 (de)
IL (1) IL96531A (de)
LU (1) LU91147I2 (de)
NL (1) NL300181I2 (de)
NZ (1) NZ236385A (de)
PT (1) PT96140B (de)
RU (1) RU2057131C9 (de)
SG (1) SG48098A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254687A (en) 1991-12-04 1993-10-19 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
CN100344615C (zh) * 2004-11-25 2007-10-24 重庆医药工业研究院有限责任公司 制备N-(吡咯并[2,3-d]嘧啶-5-基)酰基谷氨酸衍生物的方法及中间体
JP5475234B2 (ja) 2005-01-21 2014-04-16 アステックス・セラピューティクス・リミテッド 医薬化合物
EP2305681A1 (de) 2006-08-14 2011-04-06 Sicor, Inc. Kristalline Form der Pemetrexed Disäure und Verfahren zur Herstellung derselben
WO2008021411A2 (en) 2006-08-14 2008-02-21 Sicor Inc. Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid
EP1957497B1 (de) 2006-08-14 2015-09-30 Sicor, Inc. Verfahren zur herstellung von zwischenprodukten aus pemetrexed
EP1934226A2 (de) 2006-08-14 2008-06-25 Sicor, Inc. Pemetrexed-diacid von hoher reinheit und verfahren zu dessen herstellung
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (de) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmazeutische kombinationen
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
DK2985025T3 (en) * 2008-06-06 2018-03-19 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION
AU2015210337B2 (en) * 2008-06-06 2017-02-02 Boehringer Ingelheim International Gmbh Pharmaceutical combination
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
US9174991B2 (en) 2009-11-24 2015-11-03 Azad Pharmaceutical Ingredients Ag Crystalline form of pemetrexed disodium
DK2854768T3 (en) 2012-05-30 2017-06-12 Fresenius Kabi Oncology Ltd PHARMACEUTICAL COMPOSITIONS OF PEMETREXED
ITRM20120398A1 (it) 2012-08-08 2014-02-09 Berlin Chemie Ag Procedimento di sintesi pemetrexed e suo sale di lisina.
US20160051679A1 (en) 2013-04-12 2016-02-25 Actavis Group Ptc Ehf. Pemetrexed Formulation
WO2014185797A1 (en) 2013-05-17 2014-11-20 Instytut Farmaceutyczny Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid
EP3008064B1 (de) 2013-06-14 2017-11-22 Synthon B.V. Stabile argininsalze von pemetrexed und zusammensetzungen davon
US9688682B2 (en) 2013-07-16 2017-06-27 Dr. Reddy's Laboratories Limited Crystalline forms of pemetrexed tromethamine salts
NZ630292A (en) 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
US20180235969A1 (en) 2014-10-16 2018-08-23 Synthon B.V. Liquid pharmaceutical composition comprising pemetrexed
CN104672241B (zh) * 2015-01-29 2018-04-24 王磊 吡咯并[2,3-d]嘧啶类化合物及其用途
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN109195593A (zh) 2016-03-15 2019-01-11 奥莱松基因组股份有限公司 用于治疗实体瘤的lsd1抑制剂的组合
US10793573B2 (en) * 2017-08-31 2020-10-06 Duquesne University Of The Holy Spirit First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents
CN110305135B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305136A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305134B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305137A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK172753B1 (da) * 1988-05-25 1999-06-28 Lilly Co Eli N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat
US4883799A (en) * 1988-06-29 1989-11-28 The Trustees Of Princeton University N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives

Also Published As

Publication number Publication date
IL96531A0 (en) 1991-09-16
RU2057131C9 (ru) 2006-04-10
CA2031890C (en) 2000-07-25
HK1000920A1 (en) 1998-05-08
IE904445A1 (en) 1991-06-19
NL300181I2 (nl) 2005-06-01
PT96140B (pt) 1997-06-30
ES2084639T4 (es) 2013-06-11
CN1030608C (zh) 1996-01-03
DE69025723D1 (de) 1996-04-11
CA2031890A1 (en) 1991-06-12
CN1055182A (zh) 1991-10-09
NZ236385A (en) 1992-05-26
EP0432677A1 (de) 1991-06-19
DK0432677T3 (da) 1996-04-09
JPH083166A (ja) 1996-01-09
ATE135007T1 (de) 1996-03-15
JP3016876B2 (ja) 2000-03-06
SG48098A1 (en) 1998-04-17
AR245129A1 (es) 1993-12-30
LU91147I2 (fr) 2005-05-17
DE69025723T2 (de) 1996-10-31
HUT58335A (en) 1992-02-28
AU640182B2 (en) 1993-08-19
IL96531A (en) 1995-08-31
ES2084639T3 (es) 1996-05-16
DE122005000012I2 (de) 2006-02-09
AU6779190A (en) 1991-06-13
CY2076B1 (en) 1998-09-11
PT96140A (pt) 1991-09-30
RU2057131C1 (ru) 1996-03-27
NL300181I1 (nl) 2005-05-02
GR3019784T3 (en) 1996-07-31
HU218483B (hu) 2000-09-28
EP0432677B1 (de) 1996-03-06
HU908147D0 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
DE122005000012I1 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutamins{urederivate.
FI905983L (fi) Aminosyraderivat.
DE68915207D1 (de) Aminosäure-Derivate.
NO901399D0 (no) Aminosyrederivater.
FI891006A7 (fi) Aminosyraderivat.
DE59008394D1 (de) Aminosäureamid-Derivate.
NO903832D0 (no) Aminosyrederivater.
NO901033L (no) Aminosyrederivater.
FI884598A7 (fi) Aminosyraderivat.
DE3787657D1 (de) Aminosäure-Derivate.
FI892362L (fi) Buten- eller propensyraderivat.
NO901533L (no) Aminosyrederivater.
FI900024A7 (fi) Pyrrolylfenyl-substituerade hydroxamsyraderivat.
FI913179A7 (fi) Aminosyraderivat.
FI906104L (fi) Naftylsulfonylalkansyraderivat.
FI891761L (fi) Aminosyraderivat.
FI883441A7 (fi) Hydrokanelsyraderivat.
NO892728L (no) Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler.
DE69018816D1 (de) Aminosäurederivate.
DE69019217D1 (de) Perylenquinon (UCN-1028D)-Derivate.
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
NO901519D0 (no) Aminosyrederivater.
DE3854064D1 (de) Hydrochinonylphenyl-Buttersäureamid-Derivate.
ATE105549T1 (de) Aminosaeure-derivate.
ATE95518T1 (de) Aminosaeure-derivate.